Abstract:Background: Age-associated changes attenuate human blood system functionality through the aging of hematopoietic stem and progenitor cells (HSPCs), manifested in human populations an increase in myeloproliferative disease and even leukemia; therefore, study on HSPC senescence bears great significance to treat hematopoietic-associated disease. Furthermore, the mechanism of HSPC aging is lacking, especially the cellular memory mechanism. Here, we not only reported a new HSPC senescence model in vitro, but also propose and verify the cellular memory mechanism of HSPC aging of the Polycomb/Trithorax system. Methods: HSPCs (Lin-c-kit+ cells) were isolated and purified by magnetic cell sorting (MACS). The proportions and cell cycle distribution of cells were determined by flow cytometry; senescence-related β-galactosidase assay, transmission electron microscope (TEM), and colony-forming unit (CFU)-mix assay were detected for identification of the old HSPC model. Proteomic tests and RNA-seq were applied to analyze differential pathways and genes in the model cells. qPCR, Western blot (WB), and chromatin immunoprecipitation PCR (CHIP-PCR) were used to detect the gene expression of cell memory-related proteins. Knockdown of cell memory-related key genes was performed with shRNA interference. Results: In the model old HSPCs, β-gal activity, cell cycle, colony-forming ability, aging-related cell morphology, and metabolic pathway were significantly changed compared to the young HSPCs. Furthermore, we found the model HSPCs have more obvious aging manifestations than those of natural mice, and IL3 is the major factor contributing to HSPC aging in the model. We also observed dramatic changes in the expression level of PRC/TrxG complexes. After further exploring the downstream molecules of PRC/TrxG complexes, we found that Uhrf1 and TopII played critical roles in HSPC aging based on the HSPC senescence model. Conclusions: These findings proposed a new HSPC senescence model in vitro which we forecasted could be used to preliminary screen the drugs of the HSPC aging-related hemopathy and suggested cellular memory mechanism of HSPC aging.

Study on the Practicability of a New Model of Red Blood Cell Aging in Vivo Developed by Antibody-Induced Instant Hemolysis Method

New model of the RBC aging

[Advances in live-imaging aging reporter mice]

An Animal Model to Study Erythrocyte Senescence with a Narrow Time Window of Erythrocyte Production.

The Microrheological Changes in the Course of Erythrocyte Senescence after Phenylhydrazine Injection.

Studies on the biomechanical properties of maturing reticulocytes.

In vivo aging of red cell enzymes: Study of biotinylated red blood cells in rabbits

Erythrocyte Membrane Changes during Aging in Vivo

Spectroscopic Signature of Red Blood Cells in a D-Galactose-Induced Accelerated Aging Model

Computational modeling of biomechanics and biorheology of heated red blood cells

Biophysical and Biorheological Studies on the Precursor Cells at Different Stages

Measurement of Red Cell Lifespan and Aging

Evolution of surface area and membrane shear modulus of matured human red blood cells during mechanical fatigue

Recent advances and clinical applications of red blood cell lifespan measurement

A stress-induced cellular aging model with postnatal neural stem cells

Evaluation of the Effects of Methylene Blue Photochemical Viral Inactivation of Red Blood Cells by Using Animal Models

Small-animal blood exchange is an emerging approach for systemic aging research

In vitro assay for single-cell characterization of impaired deformability in red blood cells under recurrent episodes of hypoxia

Using a new HSPC senescence model in vitro to explore the mechanism of cellular memory in aging HSPCs

Enhanced Separation of Aged RBCs by Designing Channel Cross Section

EFFECT OF PHENYLHYDRAZINE INJECTION ON THE MICRORHEOLOGICAL CHARACTERISTICS OF RBCs IN THE COURSE OF ERYTHROCYTE SENESCENCE